(Q83512067)

English

Safety, tolerability and pharmacokinetics of dalcetrapib following single and multiple ascending doses in healthy subjects: a randomized, double-blind, placebo-controlled, phase I study

scientific article published on 01 January 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Safety, tolerability and pharmacokinetics of dalcetrapib following single and multiple ascending doses in healthy subjects: a randomized, double-blind, placebo-controlled, phase I study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Judith Anzures-Cabrera

2

object named as

Judith Anzures-Cabrera

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Michael Derks

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Lynn Turnbull

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Mary Phelan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

325-335

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of torcetrapib on the progression of coronary atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and tolerability of dalcetrapib

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dalcetrapib pharmacokinetics and metabolism in the cynomolgus monkey

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single-center, open-label, one-sequence study of dalcetrapib coadministered with ketoconazole, and an in vitro study of the S-methyl metabolite of dalcetrapib.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of clinically relevant drug-drug interactions when dalcetrapib is co-administered with ezetimibe

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No clinically relevant drug–drug interactions when dalcetrapib is co-administered with atorvastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03256931

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21366361%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83512067&oldid=2143627983"